The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.

Kim, Grace J

The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy. [electronic resource] - American journal of clinical oncology Apr 2016 - 136-41 p. digital

Publication Type: Journal Article

1537-453X

10.1097/COC.0000000000000036 doi


Adenocarcinoma--mortality
Adult
Carcinoma, Squamous Cell--mortality
Chemoradiotherapy--methods
Chemotherapy, Adjuvant--adverse effects
Cisplatin--administration & dosage
Docetaxel
Esophageal Neoplasms--mortality
Esophagectomy
Female
Fluorouracil--administration & dosage
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm, Residual--drug therapy
Proportional Hazards Models
Retrospective Studies
Taxoids--administration & dosage